|
 |
Chris Coburn
Executive Director
coburnc @ ccf.org
216-445-4008 |
|
|
| Commercialization |
 |
Alan Bentley
Director, Commercialization
bentlea @ ccf.org
216-444-6752 |
 |
Jeff Combs
Commercialization Associate
combsj2 @ ccf.org
216-444-5622 |
 |
Mary Kander
Senior Commercialization Officer
kanderm @ ccf.org
216-445-0827 |
 |
Peter O’Neill
Senior Commercialization Officer
oneillp2 @ ccf.org
216-445-0814 |
 |
Neil Veloso
Sr. Commercialization Officer
veloson @ ccf.org
216-444-0386 |
 |
Michael Villalobos
Commercialization Officer
villalm @ ccf.org
216-445-0812 |
| New Ventures and
Business Development |
 |
Sam Kiderman
Director, New Ventures
kiderms @ ccf.org
216-444-6898 |
 |
Jennifer Boland
Commercialization Officer
bolandj @ ccf.org
216-445-1014 |
 |
Lou Walcer
Senior Commercialization Officer
walcerl @ ccf.org
216-445-1943 |
 |
Irina Tsing
Operations Analyst
tsingi3 @ ccf.org
216-445-0619 |
 |
Shannon Schuetz
Commercialization Officer
schuets @ ccf.org
216-445-1594 |
| Business Operations |
 |
Susan Bernat
Director, Operations and Finance
bernats @ ccf.org
216-444-5538 |
 |
Caryn Cua
License Analyst
cuac @ ccf.org
216-445-0829 |
 |
Debra Cunningham
Department Coordinator
cunnind @ ccf.org
216-444-5757 |
 |
David Figueroa
Marketing Associate
figured @ ccf.org
216-444-1847 |
 |
Kimberley Gilyard
Innovation Center Coordinator
gilyark @ ccf.org
216-444-1080 |
 |
Laura Konczos
Program Coordinator
Atrial Fibrillation Innovation Center
konczol @ ccf.org
216-445-7006 |
 |
Doug Meislahn
Commercialization Analyst
meislad @ ccf.org
216-444-0906 |
 |
Linda Rudolph
Administrative Secretary
rudolpl @ ccf.org
216-445-1917 |
 |
Kimberly Woods
Administrative Secretary
woodsk @ ccf.org
216-445-3728 |
| Global Cardiovascular Innovation Center |
 |
Mark Low
Managing Director, GCIC
lowm @ ccf.org
216-445-6920 |
 |
Susan Bernat
Director, Operations and Finance
bernats @ ccf.org
216-444-5538 |
 |
Joseph Barone
Program Coordinator, GCIC
baronej2 @ ccf.org
216-445-8392 |
 |
Thomas Sudow
Director, Company Attraction
tsudow @ teamneo.org
216-363-5421 |
 |
Peter O’Neill
Senior Commercialization Officer
oneillp2 @ ccf.org
216-445-0814 |
 |
Judy McAnally
Administrative Secretary
mcanalj @ ccf.org
216-445-8922 |
| Third Frontier
Project Directors |
 |
Alan Bentley
Executive Director, AFIC
bentlea @ ccf.org
216-444-6752 |
 |
Neema Mayhugh
Executive Director, AMD
Center of Excellence
mayhugn @ ccf.org
216-445-7176 |
 |
Charles Steiner
Manager, Brain Neuromodulation Center (BNMC)
steinec @ ccf.org
216-444-9298 |
 |
Elizabeth Sump Executive
Director, Clinical
Tissue Engineering Center (CTEC)
sumpe @ ccf.org
216-445-4145 |
| Affiliated Staff |
 |
Jamie Belkin
Medical Innovation Summit Coordinator
jamie @ jamiebelkinevents.com
216-932-3448 |
 |
Karen Shanahan
Associate General Counsel
shanahk @ ccf.org
216-297-7046 |
 |
Rich Wesorick
Patent Counsel
rwesorick @ tarolli.com
216-621-2234 ext. 110 |
|
|
| Executive in Residence |
 |
George Trutza
Executive in Residence
gtrutza @ cox.net
401-884-3460 |
 |
Doug Redding
reddind @ ccf.org
617-797-1989 |
Chris Coburn,
Executive Director. Mr. Coburn has been Executive Director
of Innovations since its establishment in 2000 and is responsible
for all activities and outcomes of the department. He
is a recognized authority of technology commercialization
and has consulted and spoken on the subject throughout
North America and in 20 countries. He leads a team of
a dozen industry veterans. Mr. Coburn serves on the
board of directors of CleveX, Merlot Therapeutics, PeriTec,
PrognostiX, and BioEnterprise. He is a trustee of Hathaway
Brown School, Northeast Ohio Council of Higher Education,
and Town Hall of Cleveland. He is a former director
of the U.S. Enrichment Corporation ( NYSE:USU) and author
of numerous articles and book chapters on technology
commercialization. He was editor and co-author of Partnerships,
a key reference book on technology commercialization.
His Master’s Degree is from George Washington
University.
Alan
Bentley, Director, Commercialization.
Alan is part of a team licensing professionals dedicated
to the commercialization of medical device technologies
resulting from CCF research. His specific focus is in
cardiovascular devices and products. Prior to joining
the Cleveland Clinic, Alan was the Associate Director
of the UVA Patent Foundation, where he played a principal
role in overseeing the daily operations of their licensing
operation. Alan has been a registered Patent Agent since
1999. Alan received his masters degree in physics from
the University of Virginia, and received separate bachelor’s
degrees in electrical engineering and in physics from
Carnegie Mellon University in Pittsburgh, Pennsylvania.
Jeff Combs,
Ph.D., Commercialization Associate. Jeff’s
primary focus is the commercialization of technologies
originating from the Clinical Tissue Engineering Center.
Prior to joining CCI, he earned a Ph.D. in Cell and
Molecular Biology from the University of Texas at Austin
with a research focus in Immunology. While finishing
his graduate work, he interned at the University of
Texas Office of Technology Commercialization where he
participated in the marketing and negotiation of many
license agreements. Jeff earned a bachelor of science
in Biology from the University of Akron.
Mary Kander,
Senior Commercialization Officer. Prior to joining CCI,
she held general management and senior marketing positions
at Invacare Corporation. She was involved in valuing,
negotiating and integrating acquisitions and new technologies.
Prior to Invacare, Mary progressed through a variety
of assignments with Procter & Gamble in Cincinnati,
concluding as a group manager in the Food Technologies
Division. Mary's MBA is from the University of North
Carolina, Chapel Hill. Her primary focus is licensing.
Shannon
Schuetz, Commercialization Associate. Shannon’s
primary focus is on Cleveland Clinic's neurostimulation
portfolio. She is also the initial point of contact
for inventors, and coordinates the intake and tracking
of invention disclosures. Prior to joining CCI, Shannon
enjoyed a three-year stint as an entrepreneur in addition
to working for Merck & Co., and as a Research Associate
in the Cleveland Clinic department of Anesthesiology
Research. Shannon has a B.S. in Biology from John Carroll
University.
Neil
Veloso, Senior Commercialization Officer. Prior
to joining CCI, Mr. Veloso was with the technology
transfer office at Case Western Reserve University.
He has transactional experience with a wide range of
companies including pharmaceutical firms, medical device
and biotechnology companies, as well as early stage
entities. Mr. Veloso previously held research and development
positions at two start-up biotechnology companies. He
has a B.A. in biology from The Johns Hopkins University,
an M.S. in environmental health (cancer biology) from
Case, and an M.B.A. from the Weatherhead School of Management.
Michael Villalobos, Ph.D., Commercialization
Officer. At Innovations, Mike’s primary focus is the commercialization of medical
technologies from the Urological, Gynecological, and Gastrointestinal
disciplines. Prior to joining the Cleveland Clinic, Michael was a Technology
Manager at Purdue Research Foundation, where he managed the evaluation and
licensing of Life Science technologies to startup, small, and large
companies. Additionally, he aided in founding multiple successful startup
companies. Prior to his career in licensing, Dr. Villalobos was a Senior Process
Scientist at Abbott Laboratories where he oversaw the manufacturing of multiple
human diagnostic assays. Michael brings an extensive background in the Life
Sciences to his position, which includes a bachelor’s degree in Microbiology from
the University of Illinois – Urbana and a Ph.D. in Molecular Biology from Loyola
University Chicago. His work is published in multiple peer-reviewed journals.
| New Ventures and Business Development |
Sam Kiderman,
Ph.D., Director, New Ventures. Dr. Kiderman’s
main focus is the administration, development and growth
of new ventures/spin offs. Prior to joining CCI, he
was responsible for Clinic Care, a subsidiary of the
Cleveland Clinic, which provides multifunctional support
for the Clinic and CCI spin-offs. Sam has extensive
experience in business development and has been involved
in the organization and start-up of a number of financially
successful companies. He serves as a treasurer for PrognostiX
and OrthoMEMS and serves on the board of directors of
New Generation Technology and Foundation for Humanitarian
Aid. Prior to the Cleveland Clinic, Sam had started-up
and developed financially successful business enterprise
and held executive financial positions with several
organizations. He also served as a business Advisor/Consultant
for several Foreign Embassies. Other industries of expertise
include bio-tech, commercial real estate investments
and financial services. His B.S. in Accounting, MBA
and Ph.D. in Economics are from Moscow State University.
Jennifer
Boland, Commercialization Officer. Prior to
joining CCI, Ms. Boland was responsible for the financial
planning and analysis of several business operations
within LeapFrog, a nationally recognized venture-backed
technology company. Her experience also includes roles
with a start-up venture within Hewlett-Packard and with
an All-American ranked equity research team at Deutsche
Banc Alex. Brown. Ms. Boland received her MBA from UC
Berkeley's Haas School of Business.
Lou
Walcer, Senior Commercialization Officer. Lou
Walcer is a senior health care industry executive with
thirty years of experience in general management, business
development/strategic planning, sales, marketing, and
marketing communications. Prior to joining CCI, He
served as President of Medimop USA, a company which
developed and manufactured medical devices for drug
delivery, through to its acquisition by West Pharmaceutical
Services. Before his service with Medimop, Walcer founded
and led the biomedical consulting and implementation
services company Mediconcepts. Clients included a variety
of academic institutions, startups and multinational
drug and medical device companies. He previously served
as Senior Vice President of Business Development and
Marketing for Copernicus Gene Systems, Inc., and served
as Vice President, Business Development and Marketing
for Gliatech. Prior to his arrival in Cleveland, Walcer
served in a series of increasingly responsible marketing,
new product development and business development positions
with Wyeth’s International, USA, and Global operations.
Earlier, he served as a Product Manager at Schering-Plough,
and consulted in product management for Merck &
Co. He earned his BA from Cornell University, and his
MBA from NYU.
Susan Bernat,
Director, Operations and Finance. She is responsible for all fiduciary management including fiscal planning and other related financial activities. Susan also assists with establishing and implementing strategic goals and oversees long-range facilities planning. She also serves as the Director of Finance for the GCIC with responsibilities including development and implementation of strategy for ensuring financing of the GCIC consortium operations and management of financial performance and budgets. Prior to joining CCI, she was responsible for budget and contract negotiations within cardiology research at Cleveland Clinic. She received her undergraduate degree in Accounting from Kent State University, and an MBA from Cleveland State University.
Caryn Cua,
License Analyst. She manages all aspects of license
compliance, which includes actively monitoring and maintaining
all licenses. She is also responsible for managing royalty
audits, payments and reporting related to more than
90 active licenses. Prior to joining CCI in December
2000, she received her B.A. from John Carroll University.
Debra
Cunningham, Department Coordinator. Debra manages the Product Development Fund program, facilitates contract review for all consulting agreements and assists with the preparation and development of the department operating budget. She also coordinates special events hosted by the Innovations department, manages the orientation process for new employees and oversees the department internship program. Debra is also responsible for website development and maintenance.
David
Figueroa, Marketing Associate
Kimberley
Gilyard, Coordinator, Cleveland Clinic Innovation Center. Her primary focus is the property management of the Cleveland Clinic's Innovation Center, which is a 15,000 square foot facility that houses the Clinic's incubator/accelerator program. She is responsible for managing the daily business operations of the Innovation Center, which currently is the home to six early-stage biotech companies. She implements incubator procedures, including establishing, evaluating, and regulating all tenant polices. In addition, she assists with purchasing, relocations, and other administrative tasks.
Laura
Konczos, Program Coordinator, Atrial Fibrillation
Innovation Center. Laura is responsible for managing
the day to day operations within the AFIC. Prior to
joining CCI Laura worked with several other CCF research
areas, including Cardiovascular Medicine, Anesthesia
and Vascular.
Doug
Meislahn, Commercialization
Analyst, is a registered patent agent whose primary
role at CCI is to serve as the initial point of contact
for researchers and physicians who are considering the
commercial prospects of their inventions. In this role,
he advises inventors on their options, tracks incoming
disclosures, and assembles background information for
case managers. Prior to joining CCI, Doug received
his MBA from Carnegie Mellon University’s Tepper
School of Business. He worked for five years as a patent
examiner and has a B.S. in Physics from Davidson College.
Linda
Rudolph, Administrative Secretary. Linda manages the scheduling and meeting planning process and provides administrative support to the executive director. She works with the management team on meetings and projects as needed, and assists in the recruitment process for department personnel. Linda’s background is in executive support, having worked at Case Western Reserve University as executive assistant to several vice presidents, managing the medical school dean’s office and planning University level board and committee meetings.
Irina
Tsing, Operations Analyst. Prior to joining
CCI, Irina was responsible for feasibility studies,
financial analysis, industry analysis, and market research
for potential business opportunities at Clinic Care
(subsidiary of Cleveland Clinic). During her career
she was involved in major projects sponsored by the
U.S. Government and European Bank for Reconstruction
and Development (EBRD). Irina holds a degree in psychology
from FSU and an MBA from Cleveland State University.
Kimberly
Woods, Administrative Secretary.
| Global Cardiovascular Innovation Center |
Mark Low,
Managing Director. Mr. Low comes to GCIC with a career of building successful programs to introduce new concepts and new modalities to new markets. He has managed all facets of product and market development spanning diagnostic and interventional cardiology, interventional radiology and neuroradiology, stroke treatment, image-guided surgery, drug delivery and oncology. He has served on the senior management team of TomTec Imaging Systems, Image Guided Technologies, EKOS Corporation, and Sonus Pharmaceuticals. Prior to concentrating his focus on start-up ventures and early stage market development, Mr. Low held progressively more responsible and trailblazing positions in marketing and business development for Hewlett-Packard's Medical Products Group. Specializing in cardiovascular ultrasound, Mr. Low managed high performance cardiac diagnostic systems, introduced products to new market segments including private office and interventional cardiology, and developed new applications including 3D and stress echocardiography, and catheter-based intravascular ultrasound. In conjunction with these programs Mr. Low managed strategic relationships with various corporate partners, investors, universities, inventors, clinical investigators and manufacturers. Mr. Low received a B.A. degree in Natural Science from Johns Hopkins University, an M.S. degree in Physiology from the Medical College of Wisconsin, and an M.S. degree in Technical Communication from Rensselaer Polytechnic Institute.
Susan Bernat,
Director, Operations and Finance. She is responsible for all fiduciary management including fiscal planning and other related financial activities. Susan also assists with establishing and implementing strategic goals and oversees long-range facilities planning. She also serves as the Director of Finance for the GCIC with responsibilities including development and implementation of strategy for ensuring financing of the GCIC consortium operations and management of financial performance and budgets. Prior to joining CCI, she was responsible for budget and contract negotiations within cardiology research at Cleveland Clinic. She received her undergraduate degree in Accounting from Kent State University, and an MBA from Cleveland State University.
Joseph
Barone, Program Coordinator, Global Cardiovascular
Innovation Center. Joe is responsible for managing day
to day operations within the GCIC and facilitating communication
flow between the Cleveland Clinic and partnering GCIC
institutions. Joe holds a bachelors degree in biomedical
engineering from Case Western Reserve University.
Thomas Sudow,
Director, Company Attraction. Tom Sudow is Vice President, Attraction for Team NEO and in this role he works with GCIC as Director of Company Attraction. Prior to joining Team NEO and the GCIC, he served as Executive Director of the Beachwood, Ohio Chamber of Commerce. In his role, he coordinated economic development efforts for the City of Beachwood.
Peter O’Neill,
Senior Commercialization Officer. Prior to joining CCI, Mr.
O’Neill was Deputy Director of Battelle’s
Great Lakes Industrial Technology Center, where he facilitated
licenses and other technology transfer partnerships
with the NASA Glenn Research Center. Previously, he
worked as a process engineer for a number of investment
casting companies, supplying turbine blades to gas turbine
engine manufacturers. Peter received a B.S. in aeronautical
engineering from MIT. At CCI he is focusing on commercializing
MEMS, orthopedic, and other medical device technologies.
| Third Frontier Project Directors |
Alan
Bentley, Director, Medical Device Commercialization;
Executive Director, AFIC. Alan is part of a team licensing
professionals dedicated to the commercialization of
medical device technologies resulting from CCF research.
His specific focus is in cardiovascular devices and
products. Prior to joining the Cleveland Clinic, Alan
was the Associate Director of the UVA Patent Foundation,
where he played a principal role in overseeing the daily
operations of their licensing operation. Alan has been
a registered Patent Agent since 1999. Alan received
his masters degree in physics from the University of
Virginia, and received separate bachelor’s degrees
in electrical engineering and in physics from Carnegie
Mellon University in Pittsburgh, Pennsylvania.
Neema Mayhugh,
Ph.D., Dr. Mayhugh’s current focus is
on technology commercialization in the ophthalmic therapeutic
area. She joins CCI from Pfizer, Inc., where she was
responsible for worldwide market analytics in age-related
macular degeneration. Her previous experience also includes
strategic consulting in the biotech, pharmaceutical,
and medical device industries and research in neurodegenerative
disease at the Massachusetts General Hospital. Dr. Mayhugh
received her doctorate in Pharmacology and Toxicology
at Dartmouth College and her undergraduate degree in
Human Physiology at Boston University.
Charles
Steiner, Manager, Brain Neuromodulation Center
(BNMC), started with Cleveland Clinic in the late 1980's
developing surgical navigation systems for the fields
of neurological and spine surgery. He holds several
patents for frameless stereotactic surgery and medical
data communication. As director of product development
for the Minimally Invasive Surgery Center he developed
a multidisciplinary surgical teaching facility replete
with surgical simulators, tele-robotic systems and medical
informatics resources. As manager for the BNMC he directs
a multispeciality team of neurosurgeons, neurologists,
neuroscientists, biomedical engineers and commercial
partners to develop next generation neuromodulation
technologies. Charles earned degrees in Chemistry and
Computer Science from Case Western Reserve University.
Elizabeth
Sump, Executive Director, Clinical
Tissue Engineering Center (CTEC). Prior to joining
CCF, Ms. Sump held several senior positions at NetGenics,
Inc., including VP of Marketing and Business Development
and VP of Component Development, where she successfully
completed several corporate collaborations and facilitated
venture fundraising. After NetGenics was acquired by
LION Bioscience Inc., she was appointed Senior Director,
Corporate Development. Elizabeth began her CCF career
as a Licensing Manager for CCF Innovations. As Executive
Director for CTEC, she directs the activities of a multidisciplinary
team of researchers and clinicians at the Cleveland
Clinic, Case Western Reserve University, University
Hospitals Cleveland, NASA, and the Ohio Supercomputer
Center to develop new technologies in regenerative medicine.
She received her B.S. in Zoology from The Ohio State
University.
Jamie
Belkin, Medical Innovation Summit Coordinator
Karen
Shanahan serves as Associate Counsel in the
Office of General Counsel at Cleveland Clinic where
she is involved in a wide variety of corporate, securities,
and transactional work. Immediately prior to joining
the Clinic, Mrs. Shanahan served as Executive Vice President
for a downstream petroleum industry start up company.
Previous to that she was associated for many years with
the downstream operations of the British Petroleum Company
(now BP Amoco) where she served as Senior Counsel and
Corporate Secretary as well as Vice President Logistics;
President of BP Pipelines; and Vice President Human
Resources. She serves as a trustee of the Cleveland
Institute of Music and the Ohio Foundation of Independent
Colleges. Mrs. Shanahan received a B.A. degree in Asian
studies from Manhattanville College and a Masters Degree
in international relations from the Georgetown University
School of Foreign Service. She holds a law degree, where
she was an editor of the Law Review from Georgetown
University.
Richard
S. Wesorick, Intellectual
Property Counsel. Mr. Wesorick helps to set patent strategy,
guides inventors and participates in the screening of
all invention disclosures. Mr. Wesorick is a partner
with a Cleveland intellectual property firm, Tarolli,
Sundheim, Covell & Tummino LLP. Mr. Wesorick is
a registered patent attorney, is admitted to the Ohio
Bar, and is an active member of the American Intellectual
Property Law Association and the Cleveland Intellectual
Property Law Association. He received his undergraduate
degree in Mechanical Engineering from Purdue University
and his Juris Doctor from University of Dayton School
of Law. Before entering law school, Mr. Wesorick worked
for four years as an engineer with G.E. Aircraft Engines,
during which time he became an inventor of a U.S. Patent
(No. 5,178,003).
George
Trutza served as President of the Kendall Medical & Surgical Division and President of Tyco Healthcare Group Canada with annual sales of $600M and $150M respectively. He spent 11 years at US Surgical in a number of senior sales and marketing management roles. As Vice President of Marketing, George took over the Suture business driving it to over $200M in sales and successfully laid the foundation for the integration of the acquisition of Davis&Geck suture products. He left Tyco to join Surgicon Inc. a Connecticut based turnaround minimally invasive medical device company. From there he joined Accellent, Inc a medical device contract manufacturing company as EVP & GM of the companies Endo Division, and recently has been evaluating medical device opportunities and serving as an Executive in Residence at the Cleveland Clinic Innovation Center.
Doug
Redding. Doug has more than 30 years experience in finance and operations, most recently as Chief Operating Officer of VIMAC Ventures, an early-stage venture capital firm with investments in information technology and life sciences. In addition to managing firm operations, Doug spent a substantial portion of his time supporting portfolio company management on planning, budgeting, infrastructure and financing.
Prior to VIMAC, Doug spent 20 years as a founder and senior level executive at several early-stage technology firms, including Software Developers' Company, Cortex Corporation, CenterLine Software and edu.com. He started his career with seven years at Price Waterhouse and is a Certified Public Accountant. Doug holds a BA from Stanford University and attended Cornell and UCLA Graduate Schools of Business.
|